The metallic radioisotope of a known radiopharmaceutical chelate, 67 Ga(NOTA) (NOTA=1,4,7-triazacyclonane-1,4,7-triacetic acid), used for tumor detection, was substituted by the chemically similar but non radioactive aluminum ion. Our aim was to detect and evaluate the in vivo behavior of the chelate. For this purpose, Al(NOTA) and the related chelate Al(NODASA) (NODASA=1,4,7-triazacyclononane-1-succinic acid-4,7-diacetic acid) were studied using in vitro and in vivo 27 Al NMR spectroscopy in rats. Both chelates showed high stability towards acid catalyzed dissociation and their 
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The metallic radioisotope of a known radiopharmaceutical chelate, 67 Ga(NOTA) (NOTA=1,4,7-triazacyclonane-1,4,7-triacetic acid), used for tumor detection, was substituted by the chemically similar but non radioactive aluminum ion. Our aim was to detect and evaluate the in vivo behavior of the chelate. For this purpose, Al(NOTA) and the related chelate Al(NODASA) (NODASA=1,4,7-triazacyclononane-1-succinic acid-4,7-diacetic acid) were studied using in vitro and in vivo 27 Al NMR spectroscopy in rats. Both chelates showed high stability towards acid catalyzed dissociation and their 27 Al NMR resonances are characteristic of highly symmetrical species, with chemical shifts within the range for octahedral or pseudo-octahedral geometries. The thermodynamic stability constant of the novel chelate Al(NODASA) was estimated using 27 Al NMR. The obtained value suggested that the chelate does not undergo in vivo demetalation by transferrin. The in vivo spectroscopic studies and the analysis of blood and urine samples for Al(III) concentrations indicated that the chelates remain intact under physiological conditions and that they are mainly eliminated from the body through the kidneys.
Introduction
Metal chelates find wide applications both as diagnostic and therapeutic agents in biomedical sciences. Gadolinium chelates are being used as paramagnetic contrast agents for MRI [1] [2] [3] . Radiochelates of gamma or positron emitting metals find strong application in Nuclear Medicine, e.g, chelates of gallium-67/68, indium-111 or copper-64 in tumor detection, and chelates of yttrium-90 and rhenium-188 in internal tumor therapy [4, 5] .
Radiochelates of Ga(III) are often used in scintigraphy for diagnostic procedures [6, 7] . The radioactive 67 Ga(NOTA) (NOTA=1,4,7-triazacyclonane-1,4,7-triacetic acid) is an interesting radiopharmaceutical agent [8] . Ga NMR study [9] . Recently Geraldes et al studied other gallium chelates of triazacyclononane ligands also using 71 Ga NMR spectroscopy [10] .
We previously performed an in vivo 69 Ga NMR study with Ga(NODASA) (NODASA=1,4,7-triazacyclononane-1-succinic acid-4,7-diacetic acid) [11] .
The main goal of this work was to detect and evaluate the in vivo behavior of Al NMR spectroscopy in rats.
The non radioactive Al(III) ion, being magnetically active, has an NMR signal which may give information about the chemical structure and integrity of its chelates under in vivo conditions.
The quadrupole splitting of the Al(III) ion is small in a highly symmetrical environment but can be as large as several MHz in an asymmetrical one. Large 4 quadrupole splitting will broaden the resonance beyond detection; consequently, the observation of high resolution NMR will be limited to complexes in which the nucleus experiences a highly symmetrical environment [12] . 27 Al has a 1.5 times higher NMR sensitivity than 71 Ga and its natural abundance is 100 % compared to 40 % of 71 Ga resulting in a 3.7 fold increase in absolute sensitivity [12] . were intravenously administrated to rats and the aluminum signals of the chelates were observed by in vivo 27 Al NMR spectroscopy.
Experimental

-Synthesis
NOTA. This ligand was synthesized according to a procedure published elsewhere [14, 15] . Crystals of Al(NOTA) were prepared also according to a method described in the literature [16] .
NODASA. This ligand was prepared according to our method previously published [11] . Crystals of Al(NODASA) were prepared using 0. varied from 0.10 to 2.0). The samples were made up to a volume of 0.8 mL and the pH of each sample was adjusted to 2.0±0.1 with 1 M HCl to prevent the hydrolysis and polymerization of the aluminum ion. The solutions were allowed to equilibrate at 20±0.5 °C and 27 Al NMR spectra were acquired periodically.
The stability of the chelates towards alkaline and acidic hydrolysis was tested using solutions obtained by dissolving the respective crystals in water.
-Animal Studies
The in vivo experiments were carried out with well-fed male Sprague-Dawley rats (230 and 290 g) that had free access to a standard laboratory rat diet and drinking water ad libidum. For the experiments, the individual rats were anesthetized with 1. The relative concentrations of free aluminum and complexed aluminum in solution were quantified with 27 Al NMR spectroscopy in the pulse-acquire mode whereas T 1 and T 2 relaxation were measured with a standard inversion-recovery and a spin-echo sequence, respectively. In vivo 27 Al NMR spectra of intact rats were obtained using a surface coil for signal excitation and acquisition. A home-built single-turn coil with a diameter of 3.6 cm was used for the in situ assessment of Al(NOTA) whereas a 2-turn 1.8 cm coil was employed for a more localized detection of Al(NODASA) in rat liver. Al coils. 27 Al spectra were processed with a 40 Hz apodisation prior to Fourier transformation.
Results and discussion
-In vitro experiments
The 27 Al resonances of both chelates appear as single peaks with chemical shifts within the region of octahedral or pseudo-octahedral aluminum chelates. Al(NOTA)
has its resonance at 49 ppm [17] with a linewidth of about 60 Hz. Al(NODASA) appears at 47 ppm with a halfwidth of 80 Hz (Figure 2 ). This result is consonant with the structure of the analogous Ga(NODASA), previously determined by us using X-ray diffraction [11] . In this work we demonstrated that the chelate is electrically neutral and the metal ion is fully chelated in a slightly distorted octahedral environment. The β-carboxylate from the succinate pendant arm remains protonated and does not participate in the complexation of the metal ion. The X-ray structure of Al(NOTA) [20] similarly showed that the metal ion is also chelated by the 3 nitrogen atoms of the 
-In vivo experiments
The infusion of Al(NOTA) in isotonic NaCl solution through tail vein injection in a rat started with a rate of 4 mL/h and a dead time of 7 min. In the following period a spectrum was acquired every 7 min. After 15 min a 27 Al NMR signal appears at 45
ppm. Figure 4 depicts the time course of the spectra. After 72 min the infusion was stopped.
Al(NODASA) in isotonic NaCl solution was also infused into the tail vein of a rat at a rate of 4 mL/h. The 27 Al NMR signal appeared at 46.3 ppm after 20 min p.i. (Figure 5 ).
A broadening of the signal was observed in vivo which may be explained by higher viscosity with concomitant increase of the rotational correlation time. The infusion was stopped after 72 min.
Atomic absorption spectroscopy for aluminum showed that the blood value was 140 µM and the urine level was >8 mM. In a control rat 0.3 µM of aluminum in blood and 1.3 µM in urine were found.
27
Al NMR spectroscopy of a urine sample collected over a period of 24 hours only showed the characteristic signal of the chelate (Figure 2- b), which clearly indicates that the chelate is not metabolized during the elimination through the kidneys. The high elimination rate via the kidneys explains the relatively low blood concentration.
-Conclusions
In vivo 27 Al NMR of aluminum macrocyclic chelates was shown to be feasible.
The low in vivo 27 Al NMR signal intensity indicated low blood concentration of the chelates [13] , which is due to the high clearance rate through the kidneys. The low NMR signal intensity does not allow MR-imaging within a reasonable acquisition time although a in vivo dynamic spectroscopic observation of the metallic chelates is possible.
The short T 1 time allows a fast acquisition and the relatively small half-width of the signal renders these aluminum chelates potential compounds for studies of biomedical interest. The possibility of coupling NODASA-metal chelates to biomolecules through the free pendant arm [11, 21] determined by potentiometric titration [11] . 
